See the Full Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Mother's Day
Baseball
Pope Francis
Social Media
Wrestling
NCAA
Catholic Church
Donald Trump
Vladimir Putin
Education
Artificial Intelligence
Soccer
Published • loading... • Updated

Indian Immunologicals gets DCGI nod for Measles-Rubella vaccine

Summary by Ground News
Vaccine maker Indian Immunologicals (IIL) has received approval from the Drugs Controller General of India (DGCI) and Telangana State Drug Control Administration (DCA) for manufacturing Measles-Rubella (MR) vaccine. IIL is collaborating with Vietnam's Center for Research and Production of Vaccines and Biologicals, also known as Polyvac.

1 Articles

All
Left
1
Center
Right
The HinduThe Hindu
Lean Left

Indian Immunologicals gets DCGI nod for Measles-Rubella vaccine

Vietnam’s Center for Research and Production of Vaccines and Biologicals, also known as Polyvac, will be supplying the measles vaccine component, while the rubella vaccine component will be produced by IIL to manufacture a combined MR vaccine.

·India
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Hindu broke the news in India on Monday, March 27, 2023.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Asia

Asia

Measles

Measles

Vaccines

Vaccines

Vietnam

Vietnam

News
For You
SearchBlindspotLocal